Similarities between Skin cancer and Trametinib
Skin cancer and Trametinib have 4 things in common (in Unionpedia): BRAF (gene), Dabrafenib, MEK inhibitor, Melanoma.
BRAF (gene)
BRAF is a human gene that encodes a protein called B-Raf.
BRAF (gene) and Skin cancer · BRAF (gene) and Trametinib ·
Dabrafenib
Dabrafenib (trade name Tafinlar, GSK2118436) is a drug for the treatment of cancers associated with a mutated version of the gene BRAF.
Dabrafenib and Skin cancer · Dabrafenib and Trametinib ·
MEK inhibitor
A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.
MEK inhibitor and Skin cancer · MEK inhibitor and Trametinib ·
Melanoma
Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes.
The list above answers the following questions
- What Skin cancer and Trametinib have in common
- What are the similarities between Skin cancer and Trametinib
Skin cancer and Trametinib Comparison
Skin cancer has 94 relations, while Trametinib has 14. As they have in common 4, the Jaccard index is 3.70% = 4 / (94 + 14).
References
This article shows the relationship between Skin cancer and Trametinib. To access each article from which the information was extracted, please visit: